These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8493575)

  • 1. Repression of MHC class I gene promoter activity by two-exon Tat of HIV.
    Howcroft TK; Strebel K; Martin MA; Singer DS
    Science; 1993 May; 260(5112):1320-2. PubMed ID: 8493575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the role of the second coding exon of the HIV-1 Tat protein in virus replication and MHC class I downregulation.
    Verhoef K; Bauer M; Meyerhans A; Berkhout B
    AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1553-9. PubMed ID: 9840288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Tat represses transcription from the mannose receptor promoter.
    Caldwell RL; Egan BS; Shepherd VL
    J Immunol; 2000 Dec; 165(12):7035-41. PubMed ID: 11120831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1: a molecular toolkit for analysis of major histocompatibility complex class I expression.
    Howcroft TK
    Eur J Clin Invest; 2000 Aug; 30(8):657-9. PubMed ID: 10964156
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV-1 tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class I genes.
    Weissman JD; Brown JA; Howcroft TK; Hwang J; Chawla A; Roche PA; Schiltz L; Nakatani Y; Singer DS
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11601-6. PubMed ID: 9751712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of tumor necrosis factor-beta expression by the human immunodeficiency virus type-1 tat protein in central nervous system-derived glial cells.
    Yang L; Morris GF; Wang Z; Bohan Morris C
    Virus Res; 1997 Aug; 50(2):195-203. PubMed ID: 9282784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV Tat represses transcription of the beta 2-microglobulin promoter.
    Carroll IR; Wang J; Howcroft TK; Singer DS
    Mol Immunol; 1998 Dec; 35(18):1171-8. PubMed ID: 10199391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV Tat protein requirements for transactivation and repression of transcription are separable.
    Brown JA; Howcroft TK; Singer DS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jan; 17(1):9-16. PubMed ID: 9436753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication.
    Kameoka M; Rong L; Götte M; Liang C; Russell RS; Wainberg MA
    J Virol; 2001 Mar; 75(6):2675-83. PubMed ID: 11222691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of HIV-1 to escape from the host immune surveillance.
    Kamp W; Berk MB; Visser CJ; Nottet HS
    Eur J Clin Invest; 2000 Aug; 30(8):740-6. PubMed ID: 10964167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway.
    Ott M; Emiliani S; Van Lint C; Herbein G; Lovett J; Chirmule N; McCloskey T; Pahwa S; Verdin E
    Science; 1997 Mar; 275(5305):1481-5. PubMed ID: 9045614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120.
    Cheng-Mayer C; Shioda T; Levy JA
    J Virol; 1991 Dec; 65(12):6931-41. PubMed ID: 1658383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1.
    Li CJ; Wang C; Friedman DJ; Pardee AB
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5461-4. PubMed ID: 7777531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein.
    Chowdhury M; Taylor JP; Tada H; Rappaport J; Wong-Staal F; Amini S; Khalili K
    Oncogene; 1990 Dec; 5(12):1737-42. PubMed ID: 2178236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of HIV-1 Tat on expression of HLA class I molecules.
    Matsui M; Warburton RJ; Cogswell PC; Baldwin AS; Frelinger JA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Mar; 11(3):233-40. PubMed ID: 8603259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of heterologous downstream sequences on the activity of the HIV-1 promoter and its response to Tat.
    Greenberg ME; Mathews MB
    Nucleic Acids Res; 1997 Dec; 25(24):5017-24. PubMed ID: 9396810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymes targeted to cleave HIV-1 TAT/Rev RNA.
    Unwalla H; Banerjea AC
    Biochem J; 2001 Jul; 357(Pt 1):147-55. PubMed ID: 11415445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcellular transactivation by the human immunodeficiency virus type 1 tat protein.
    Helland DE; Welles JL; Caputo A; Haseltine WA
    J Virol; 1991 Aug; 65(8):4547-9. PubMed ID: 2072464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tat protein of human immunodeficiency virus type 1 is a monomer when expressed in mammalian cells.
    Rice AP; Chan F
    Virology; 1991 Nov; 185(1):451-4. PubMed ID: 1656598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.